Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated calcium channels in vascular smooth muscle (VSM), particularly the L-type CaV1.2 channel, are key mediators of calcium influx, initiating contraction and regulating vascular tone. They are primary determinants of blood pressure and are targeted by calcium channel blockers for treating hypertension. Dysregulation is implicated in cardiovascular diseases and diabetes.
Calcium channel blockade
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated Calcium Channel Subunit Alpha 1C (CaV1.2).